GSK gets European marketing rights for Nucala to treat asthma – The Pharma Letter (registration)


The Pharma Letter (registration)

GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration)
UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the …
EU OK for GSK's novel asthma biologicPharmaTimes
Nucala Now Available for Severe AsthmaMonthly Prescribing Reference (registration)
EU Grants Marketing Authorization to GSK's NucalaDrug Discovery & Development
StreetInsider.com –The FINANCIAL –RTT News
all 18 news articles »

View full post on asthma – Google News

School district gets grant to help treat students with asthma – Laredo Morning Times


Laredo Morning Times

School district gets grant to help treat students with asthma
Laredo Morning Times
United ISD was the beneficiary of a grant from the Laredo Diploma Plus Foundation. The nonprofit organization gave United ISD a grant to purchase nebulizers that will be given to each campus to treat students with asthma. Pictured, from left, at a

View full post on asthma – Google News